DeSantis Damon purchased $1.0M of CELH

Celsius Holdings (CELH) stock rose as CEO John Fieldly and Director Damon DeSantis bought nearly $2 million in shares, and the company announced a $300 million share repurchase program. Insider buying and the buyback suggest management believes the stock is undervalued. The company's growth in the U.S. energy drink market and strong cash generation support its long-term outlook, but rising debt and thinner margins pose risks.

Celsius Holdings (CELH) faces a securities class action lawsuit over alleged misstatements about Alani Nu energy drinks. The stock is down 38.09% YTD and 47.25% over one year, though it saw a 6.45% gain in the last month. Analysts debate its fair value, with some seeing it as undervalued at $47.37 and others noting its high P/E ratio of 118.7x compared to peers.

Celsius Holdings (CELH), Norwegian Cruise Line (NCLH), and Roblox (RBLX) stocks hit 52-week lows. CELH reported 138% revenue growth but core brand sales slowed. NCLH faces high fuel costs and weak bookings. RBLX's user growth slowed due to safety changes. All stocks fell: CELH -5%, NCLH -3%, RBLX -2%.

Celsius (CELH) shares fell 5.9% after Deutsche Bank downgraded the stock to Hold with a $35 target, citing weakened trends and delayed recovery. The company's Q2 results missed estimates, with revenue at $817.9M (vs. $872M expected) and EPS at $0.36 (vs. $0.42 expected). Operating margin compressed to 9.2% from 19.3% YoY. The stock is down 30.9% YTD and 49.1% from its 52-week high.

Deutsche Bank downgraded Celsius Holdings (CELH) to Hold, raising its price target to $35. The bank cited weaker core brand trends, delayed recovery expectations until 2027, and a recent 30% share price increase. It forecasts Q4 revenue of $738M, below consensus, and adjusted EBITDA of $149M, nearly 10% below consensus, due to input-cost inflation and other factors.

Celsius Holdings (CELH) shares fell 5.1% premarket Thursday after Deutsche Bank downgraded the stock to Hold from Buy, citing weak core brand performance and delayed recovery. Analyst Steve Powers raised the price target to $35 from $30 but expressed concerns about sustained growth. The stock had risen 30% in the past month, partly due to investor expectations of operational improvements.